Clinical Trials Directory

Trials / Unknown

UnknownNCT05970445

Clinical Phenotypic Characteristics of SC26A4

Clinical Phenotypic Characteristics of the Solute Carrier Family 26 Member 4 (SC26A4) Mutation in Pendred Syndrome/Nonsyndromic Enlarged Vestibular Aqueduct (PS/NSEVA)

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The presence or absence of SC26A4, whether combined with Mondini malformation, and patient age, are important factors affecting the degree of hearing loss in the Chinese population.

Detailed description

To summarize the Solute Carrier Family 26 Member 4 (SLC26A4) mutation and clinical phenotypic characteristics of Pendred Syndrome/Nonsyndromic Enlarged Vestibular Aqueduct (PS/NSEVA) patients and provide evidence supporting the clinical diagnosis and genetic counseling of patients with PS/NSEVA. A retrospective cohort study for the Chinese population is needed.

Conditions

Timeline

Start date
2023-05-15
Primary completion
2023-08-01
Completion
2023-08-31
First posted
2023-08-01
Last updated
2023-08-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05970445. Inclusion in this directory is not an endorsement.